Cargando…

Dihydromyricetin Inhibits Tumor Growth and Epithelial-Mesenchymal Transition through regulating miR-455-3p in Cholangiocarcinoma

Cholangiocarcinoma (CCA) leads to poor prognosis due to high aggressiveness and common chemoresistance. Dihydromyricetin (DMY), the main bioactive compound isolated from Ampelopsis grossedentata, exhibits broad anti-tumor effects. This study aimed to investigate the inhibitory effect of DMY on CCA t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xin, Yang, Zhou-Sheng, Cai, Wen-Wu, Deng, Yang, Chen, Lei, Tan, Sheng-Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425191/ https://www.ncbi.nlm.nih.gov/pubmed/34539879 http://dx.doi.org/10.7150/jca.61311

Ejemplares similares

Dihydromyricetin inhibits cell proliferation, migration, invasion and promotes apoptosis via regulating miR-21 in Human Cholangiocarcinoma Cells
por: Chen, Lei, et al.
Publicado: (2020)

miR455 is linked to hypoxia signaling and is deregulated in preeclampsia
por: Lalevée, S, et al.
Publicado: (2014)

Epithelial–Mesenchymal Transition in Liver Fluke-Induced Cholangiocarcinoma
por: Sawanyawisuth, Kanlayanee, et al.
Publicado: (2021)

MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition
por: Hsiao, Sheng-Yen, et al.
Publicado: (2023)

MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression
por: Zu, Chao, et al.
Publicado: (2017)

Expression profile and biological function of miR-455-5p in colorectal carcinoma
por: Wang, Jinqiu, et al.
Publicado: (2019)

Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer
por: Guo, Jian, et al.
Publicado: (2018)

Identification of exosomal miR-455-5p and miR-1255a as therapeutic targets for breast cancer
por: Xin, Ying, et al.
Publicado: (2020)

MiR-455 targeting SOCS3 improve liver lipid disorders in diabetic mice
por: Fang, Shu, et al.
Publicado: (2020)

Extracellular vesicle-encapsulated miR-30e suppresses cholangiocarcinoma cell invasion and migration via inhibiting epithelial-mesenchymal transition
por: Ota, Yu, et al.
Publicado: (2018)

MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer
por: Wu, Chia-Lun, et al.
Publicado: (2016)

miR-506 Regulates Epithelial Mesenchymal Transition in Breast Cancer Cell Lines
por: Arora, Himanshu, et al.
Publicado: (2013)

Restoration of miR-1228* Expression Suppresses Epithelial-Mesenchymal Transition in Gastric Cancer
por: Jia, Litao, et al.
Publicado: (2013)

miR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition
por: Wang, Lin, et al.
Publicado: (2015)

Potential Target miR-455 Delaying Arterial Stenosis Progression Through PTEN
por: Lin, Ruoran, et al.
Publicado: (2021)

miR-455 Inhibits the Viability and Invasion by Targeting RAB18 in Hepatocellular Carcinoma
por: Wang, Chenghong, et al.
Publicado: (2021)

Akt Protein Kinase, miR-200/miR-182 Expression and Epithelial-Mesenchymal Transition Proteins in Hibernating Ground Squirrels
por: Lee, Yang-ja, et al.
Publicado: (2018)

Hypo Adenosine-to-Inosine miR-455-5p Editing Promotes Melanoma Growth and Metastasis
por: Shoshan, Einav, et al.
Publicado: (2015)

Regulation of cell growth and migration by miR-96 and miR-183 in a breast cancer model of epithelial-mesenchymal transition
por: Anderson, Olivia, et al.
Publicado: (2020)

Role of AP-2α and MAPK7 in the regulation of autocrine TGF-β/miR-200b signals to maintain epithelial-mesenchymal transition in cholangiocarcinoma
por: Zhang, Dawei, et al.
Publicado: (2017)

MicroRNA miR-509-3p inhibit metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma
por: Zhang, Huiming, et al.
Publicado: (2021)

Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma
por: Liu, Aibin, et al.
Publicado: (2017)

Role of miR153 and miR455-5p Expression in Oral Squamous Cell Carcinoma Isolated from Plasma
por: Baber, Sajjad, et al.
Publicado: (2021)

miR-455 Functions as a Tumor Suppressor Through Targeting GATA6 in Colorectal Cancer
por: Yunqi, Hua, et al.
Publicado: (2019)

MicroRNA-455-5p Contributes to Cholangiocarcinoma Growth and Mediates Galangin's Anti-Tumor Effects
por: Deng, Xu, et al.
Publicado: (2021)

Reduction of Bladder Cancer Chemosensitivity Induced by the Effect of HOXA-AS3 as a ceRNA for miR-455-5p That Upregulates Notch1
por: Chen, Dajin, et al.
Publicado: (2021)

The SNAIL/miR-128 axis regulated growth, invasion, metastasis, and epithelial-to-mesenchymal transition of gastric cancer
por: Yu, Wei-Wei, et al.
Publicado: (2017)

Downregulation of miR-22 Contributes to Epithelial-Mesenchymal Transition in Osteosarcoma by Targeting Twist1
por: Zhu, Shu-tao, et al.
Publicado: (2020)

MiR-455-5p Suppresses the Progression of Prostate Cancer by Targeting CCR5
por: Xing, Qianwei, et al.
Publicado: (2019)

Clinical significance of the serum miR-455-5p expression in patients with neonatal sepsis
por: Mao, Yue-Yan, et al.
Publicado: (2021)

miR-215 promotes epithelial to mesenchymal transition and proliferation by regulating LEFTY2 in endometrial cancer
por: Gao, Xiaoxu, et al.
Publicado: (2018)

Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203
por: Gu, Yulei, et al.
Publicado: (2020)

MiR-218 regulates epithelial–mesenchymal transition and angiogenesis in colorectal cancer via targeting CTGF
por: Lun, Weijian, et al.
Publicado: (2018)

Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma
por: Liu, Aibin, et al.
Publicado: (2021)

miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion
por: Chen, Dahu, et al.
Publicado: (2014)

Dynamics and plasticity of the epithelial to mesenchymal transition induced by miR-200 family inhibition
por: Haraguchi, Takeshi, et al.
Publicado: (2016)

miR-155 promotes proliferation and epithelial-mesenchymal transition of MCF-7 cells
por: Liu, Xiaoyan, et al.
Publicado: (2021)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
por: Qiu, Shuwei, et al.
Publicado: (2013)

miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer
por: Yu, Jingshuang, et al.
Publicado: (2014)

Up-regulated miR-133a orchestrates epithelial-mesenchymal transition of airway epithelial cells
por: Chen, Linjie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_msipt0qqbcrh3to7sbj514p2uc